The first patients have been recruited for a revolutionary trial, led Professor Jeremy Chataway (Ïã¸ÛÁùºÏ²Ê Queen Square Institute of Neurology), that will transform the way that treatments are tested for progressive multiple sclerosis (MS).
More: Ïã¸ÛÁùºÏ²Ê News